EXTRACRANIAL HEAD AND NECK - PET IMAGING WITH 2-[F-18]FLUORO-2-DEOXY-D-GLUCOSE AND MR IMAGING CORRELATION

被引:217
作者
JABOUR, BA
CHOI, Y
HOH, CK
REGE, SD
SOONG, JC
LUFKIN, RB
HANAFEE, WN
MADDAHI, J
CHAIKEN, L
BAILET, J
PHELPS, ME
HAWKINS, RA
ABEMEYOR, E
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL SCI,10833 LE CONTE AVE,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,SCH MED,NUCL MED LAB,LOS ANGELES,CA 90024
[3] UNIV CALIF LOS ANGELES,SCH MED,BIOMED & ENVIRONM SCI LAB,LOS ANGELES,CA 90024
[4] UNIV CALIF LOS ANGELES,SCH MED,CRUMP INST BIOL IMAGING,LOS ANGELES,CA 90024
[5] UNIV CALIF LOS ANGELES,SCH MED,DEPT HEAD & NECK SURG,LOS ANGELES,CA 90024
关键词
EMISSION CT; FLUORINE; HEAD AND NECK NEOPLASMS; RADIONUCLIDE STUDIES; MAGNETIC RESONANCE (MR); COMPARATIVE STUDIES;
D O I
10.1148/radiology.186.1.8416578
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to define and quantitate the normal anatomy of the extracranial head and neck with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET). This information was used to study 12 patients with primary squamous cell carcinomas. In all cases, the lymphoid tissue of the Waldeyer ring and the palatine and lingual tonsils could be differentiated from the airway, striated muscle, osseous structures, and salivary glands. Striated muscle had markedly less activity than lymphoid or salivary gland tissue. In the 12 patients with primary tumors, FDG PET depicted the tumor as an area of increased activity significantly higher than that of normal tissue. In one instance, FDG PET allowed detection of a tumor not seen at magnetic resonance (MR) imaging or computed tomography. Of the 34 lymph nodes positive for carcinoma, 24 were positive according to MR size criteria and 25 were detected with FDG PET. FDG PET allowed detection of three nonenlarged metastatic nodes that were negative at MR imaging.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 25 条
[1]  
DICHIRO G, 1987, INVEST RADIOL, V22, P360
[2]   GLUCOSE-UTILIZATION OF CEREBRAL GLIOMAS MEASURED BY [F-18] FLUORODEOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY [J].
DICHIRO, G ;
DELAPAZ, RL ;
BROOKS, RA ;
SOKOLOFF, L ;
KORNBLITH, PL ;
SMITH, BH ;
PATRONAS, NJ ;
KUFTA, CV ;
KESSLER, RM ;
JOHNSTON, GS ;
MANNING, RG ;
WOLF, AP .
NEUROLOGY, 1982, 32 (12) :1323-1329
[3]  
DICHIRO G, 1988, J NUCL MED, V29, P421
[4]  
HABERKORN U, 1991, J NUCL MED, V32, P1548
[5]   PET IN CLINICAL ONCOLOGY [J].
HAWKINS, RA ;
PHELPS, ME .
CANCER AND METASTASIS REVIEWS, 1988, 7 (02) :119-142
[6]  
HAWKINS RA, 1991, J NUCL MED, V32, P1555
[7]  
HOFFMAN E J, 1986, P237
[8]  
HOH C K, 1991, Journal of Nuclear Medicine, V32, P920
[9]   NON-INVASIVE DETERMINATION OF LOCAL CEREBRAL METABOLIC-RATE OF GLUCOSE IN MAN [J].
HUANG, SC ;
PHELPS, ME ;
HOFFMAN, EJ ;
SIDERIS, K ;
SELIN, CJ ;
KUHL, DE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 238 (01) :E69-E82
[10]  
IDO T, 1978, J LABELLED COMPOUNDS, V14, P174